Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 4 Neoplasms 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Healthy Participants 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solid Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Head and Neck Neoplasms 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Iodine-131 6 selpercatinib 5 Magnetic Resonance Spectroscopy 5 Vemurafenib 4 Thyroidectomy 4 lenvatinib 3 dabrafenib 3 Transurethral Resection of Prostate 3 Thyrotropin Alfa 3 Sunitinib 3 vandetanib 2 trametinib 2 entrectinib 2 cobimetinib 2 cabozantinib 2 X-Rays 2 Trastuzumab 2 Thyroid (USP) 2 Surgical Procedures, Operative 2 Specimen Handling 2 Sorafenib 2 Rosiglitazone 2 Radiofrequency Ablation 2 Lymph Node Excision 2 Gefitinib 2 Everolimus 2 Bortezomib 2 AZD 6244 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507775 2024-04-11

DIGUP-TC

Radboud University Medical Center

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡